The Online Investor
Daily M&A
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
Medical Instruments & Supplies M&A image Medical Instruments & Supplies M&A » By The Online Investor Staff, updated Sat., Apr. 27, 11:11 AM Recent mergers and acquisitions in the Medical Instruments & Supplies M&A category.

Slide #50. Boston Scientific Bard Electrophysiology

Acquirer: Boston Scientific (NYSE:BSX)
Acquiree: Bard Electrophysiology
Details: Boston Scientific Corporation (NYSE:BSX) today closed on its previously announced agreement to acquire Bard EP, the electrophysiology (EP) business of C.R. Bard, Inc. The completion of this transaction advances Boston Scientific's ability to more comprehensively serve the rapidly expanding global EP market.

Boston Scientific develops, manufactures and markets medical devices used in a range of interventional medical specialties. Co.'s MedSurg segment includes: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat urological and pelvic conditions, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, incontinence and pelvic floor disorders. Co.'s Rhythm and Neuro segment develops and manufactures a range of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.

Boston Scientific SEC Filing Email Alerts Service

Preferred: BSX.PRA



Open the BSX Page at The Online Investor »

Company Name:  Boston Scientific Corp.
Website:  www.bostonscientific.com
Sector:  Medical Instruments & Supplies
Number of ETFs Holding BSX:  96
Total Market Value Held by ETFs:  $12.85B
Total Market Capitalization:  $106.97B
% of Market Cap. Held by ETFs:  12.02%
 

Open the BSX Page at The Online Investor (in a new window) »

April 27, 2024    11:11 AM Eastern
Quotes delayed 20 minutes

Email EnvelopeFree BSX Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Strong Buy (3.71 out of 4)
68th percentile
(ranked higher than approx. 68% of all stocks covered)

Analysts' Target Price:
BSX Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Medical Instruments & Supplies M&A - Slide 50 of 100 | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.